Entering text into the input field will update the search result below

Imprimis Pharma up 15%

  • Thinly traded Imprimis Pharmaceuticals (IMMY-OLD +15.2%) is the latest tiny biotech/drugmaker to spike. Shares are up on more than 50% higher volume, albeit on turnover of only 245K.
  • The company uses compounding pharmacies to formulate and distribute its offerings, focused on ophthalmic uses.
  • At the end June it had $4.2M in cash and equivalents. Operations generated $400K in cash in H1.
  • Q2 sales were $10.4M, up 53% from a year ago.

Recommended For You

Related Stocks

SymbolLast Price% Chg
IMMY-OLD--
Imprimis Pharmaceuticals, Inc.